VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale
VSee Health provided a business update following the May 31 sale of VSee Lab, reporting pro-forma revenue growth of 60% to $8 million in 2025 and 70% to $2.5 million in Q1 2026. The company expects to reduce annual operating expenses by approximately $6.0 million as it refocuses on its iDoc telehealth platform and enterprise solutions.
Key figures
- Guidance
- $20 million revenue and profitability over the next 12 months
- Revenue 2025
- 8000000
- Revenue q1 2026
- 2500000
- Annual opex reduction
- 6000000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.